CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy
Kühnöl, Caspar, Herbarth, Monique, Föll, Jürgen, Staege, Martin S.
and Kramm, Christof
(2013)
CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy.
Cancer Immunology, Immunotherapy 62 (12), pp. 1797-1809.
Date of publication of this fulltext: 19 Dec 2024 08:32
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Cancer Immunology, Immunotherapy | ||||
| Publisher: | SPRINGER | ||||
|---|---|---|---|---|---|
| Place of Publication: | NEW YORK | ||||
| Volume: | 62 | ||||
| Number of Issue or Book Chapter: | 12 | ||||
| Page Range: | pp. 1797-1809 | ||||
| Date | 2013 | ||||
| Institutions | Medicine > Lehrstuhl für Kinder- und Jugendmedizin | ||||
| Identification Number |
| ||||
| Keywords | ACTIVATED PROTEIN-KINASE; DENDRITIC CELL VACCINATION; TUMOR-NECROSIS-FACTOR; CD4 T-CELLS; PHASE-I/II TRIAL; MALIGNANT GLIOMA; 4-1BB LIGAND; COSTIMULATORY MOLECULE; PROSTAGLANDIN E-2; SIGNALING PATHWAY; Glioblastoma; Dendritic cells; CD137; P38MAPK inhibitors; CD25 | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 62040 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric